Publications | Pharmacists & Patient Outcomes
Pharmacist & Outcomes – ALL
CONCLUSIONS: A primary care embedded virtual intervention involving pharmacist-led tapering and mindfulness-informed CBT sessions to support benzodiazepine deprescribing is feasible, acceptable, may reduce older adults' benzodiazepine use, and warrants multi-site testing. [...]
CONCLUSIONS: These findings suggest that the physician-pharmacist collaborative model could improve the long-term quality and efficiency of T2D management and reduce medical costs in underresourced areas globally. Patients with T2D, especially those with central obesity or high cardiovascular risk, may benefit more from collaborative clinics. [...]
CONCLUSION: This study indicates that utilization of a pharmacist-led interchange protocol may improve the order processing time for biosimilars. Focused efforts could prioritize comparison of the rates of discontinuation for adalimumab products. [...]
CONCLUSION: Our findings support nonprescribing of antibiotics at follow-up for asymptomatic patients, despite a positive urine culture, as an appropriate stewardship intervention for ED and UC patients to prevent unnecessary antibiotic exposure. [...]
CONCLUSIONS: This underpowered study found no evidence of pain differences between ABI-MTM and SMC, tentatively suggesting possible alcohol-opioid co-use improvements associated with the intervention without worsening pain. [...]
No abstract [...]
CONCLUSIONS: This evaluation furthers what is understood regarding barriers to implementing care bundles within rural healthcare contexts. Our findings suggested that clinicians in rural settings felt constrained in their ability to take on new tasks and expand their practice models due to staffing shortages and heavy workload demands. Some clinicians [...]
CONCLUSION: The pharmacist-led service was feasible to deliver, acceptable to patients and supported the operationalisation of guideline-directed SGLT2i prescribing. Further longitudinal studies are needed to determine clinical and economic outcomes. [...]
CONCLUSIONS: This study identified priority outcomes for evaluating the impact of pharmacist prescribing and their measurability, encompassing clinical, safety, economic, and patient perspectives. [...]
CONCLUSION: Spanish-speaking patients exposed to clinical pharmacist care observed significant improvements in glycemic control and timely preventative care screening. [...]
BackgroundsThe prevalence of oral and malnutrition disorders is quite high in patients with hematological malignancies which may complicate cancer management resulting in poor prognosis, lower quality of life (QoL) and more deterioration of patient-related outcomes. The aim of this study was to assess the impact of clinical pharmacist provision of [...]
Despite the broad coverage offered by Taiwan's National Health Insurance system, attention-deficit/hyperactivity disorder (ADHD) care continues to face a critical "leaky pipeline" problem. There is a clear gap between diagnostic prevalence and long-term treatment retention. This perspective article applies the SPIDER (Sample, Phenomenon of Interest, Design, Evaluation, Research type) framework [...]
CONCLUSION: Pharmacist-led CMM and tailored education effectively encourage patient engagement and openness to medication tapers. Continued efforts are needed to reduce concurrent prescribing of BZDs and opioids. [...]
CONCLUSIONS: This pilot study underscores the critical role of pharmacist-led education for patients with primary open-angle glaucoma in improving treatment outcomes, particularly in achieving IOP targets and therby reducing the risk of vision loss. Future research involving larger cohorts and longer follow-up is necessary to further validate these findings. [...]
CONCLUSIONS: The brief pharmacist-led intervention was effective in improving attitudes toward medication and behavioral adherence among patients receiving antipsychotic treatment in our study group. These findings underscore the importance of active pharmacist engagement for supporting medication adherence. [...]
CONCLUSIONS AND RELEVANCE: This cluster randomized trial found that a centralized consultant pharmacist model was feasible, integrated well into primary care workflows, and resulted in high practitioner acceptance of recommendations; however, it did not significantly reduce opioid or benzodiazepine prescribing or falls within 1 year. These results suggest that more [...]
CONCLUSION: Pharmacist-led interventions in interprofessional primary care settings contributed to the appropriateness of pharmacotherapy and satisfaction of older adults under evaluation for or living with a NCD after a six-month follow-up. [...]
CONCLUSION: This evaluation demonstrated the impact of clinical pharmacists serving as prescribers in improving COPD management in rural settings. The sustainment factors identified can be utilized to inform the expansion of similar, team-based healthcare programs across rural settings. [...]
CONCLUSIONS AND RELEVANCE: This large-scale cohort study found that the use of an FPS was not associated with lower risk of death or hospitalization from any cause. However, the results generated a clinically important hypothesis that FPS use may be associated with slightly lower risk of death among older patients [...]
CONCLUSIONS: Most studies reported positive effects of pharmacist-led interventions on medication adherence and asthma control, highlighting the potential of these interventions to improve patient outcomes. Although all but one study applied BCTs, the limited diversity in the types of BCTs utilized, and the limited evaluation of satisfaction, costs, and pharmacist [...]
CONCLUSIONS: Our study demonstrates that comprehensive machine learning optimization can achieve strong predictive performance for identifying patients who would benefit from pharmacist intervention. The clinical prediction model, trained exclusively on clinical variables, provides a robust framework for personalized TB treatment resource allocation. Supportive transcriptomic analyses provide biological context but are [...]
CONCLUSIONS: Pharmacist-developed educational leaflets can support short-term knowledge acquisition and are perceived positively by women across age groups. These findings highlight the potential role of community pharmacies in delivering accessible written health education, while underscoring the need for future studies to assess long-term knowledge retention, behavioral outcomes, and topic-specific, targeted [...]
CONCLUSION: Although both video and AI chatbot interventions improved patient knowledge, engagement level-not modality type-emerged as the critical determinant of outcomes. AI chatbots can effectively address knowledge gaps about pharmacist roles when patients actively participate in the learning process. [...]
CONCLUSIONS AND RELEVANCE: In this randomized clinical trial, adding proactive, protocol-driven clinical pharmacist outreach into collaborative team-based care improved medication optimization and patient outcomes. This approach provides an evidence-based strategy for reducing the risk of developing severe hypoglycemia in individuals with T2D at high risk, enhancing patient safety, and potentially [...]
Bacteremia is a potentially life-threatening infection, especially if sepsis or septic shock develops. The 2021 Surviving Sepsis Campaign recommends initiating antibiotics within the first hour for septic shock to improve patient outcomes. The objective of this study is to assess the clinical impact of real-time pharmacist review of blood culture [...]
CONCLUSIONS: Pharmacist-led interprofessional medication reviews may reduce drug costs and the number of unnecessary and potentially harmful drugs in nursing homes. [...]
CONCLUSION: A pharmacist-driven discharge antibiotic intervention significantly improved the appropriateness of antibiotic prescribing in community hospitals. These findings support the role of pharmacists in enhancing antimicrobial stewardship at important care transitions. [...]
Background/Objectives: Older adults with chronic kidney disease (CKD) are particularly vulnerable to polypharmacy-related adverse outcomes due to altered pharmacokinetics, multimorbidity, and increased susceptibility to medication-related harm. Polypharmacy in CKD is associated with falls, hospitalizations, and functional decline. Clinical pharmacist-led medication reviews may mitigate these risks; however, access barriers limit their [...]
CONCLUSIONS: The clinical pharmacist-led MDT model enhances carbapenem-prescribing appropriateness and fosters interprofessional collaboration. Its implementation was associated with shorter hospital stays and improvements in key clinical indicators, including reduced ICU admission and mortality. However, the observed shifts in resistant pathogen epidemiology underscore that antimicrobial stewardship strategies must be integrated with [...]
Antimicrobial resistance (AMR) undermines clinical care. Thus, ensuring appropriate antimicrobial therapy is crucial in global and national AMR countermeasures. This narrative review aimed to summarize pharmacist-led antimicrobial stewardship interventions in Japan and discuss their practical and clinical significance across inpatient, outpatient, and community settings. In inpatient care, antimicrobial stewardship programs [...]
BACKGROUND: Venous thromboembolism (VTE) is a common and potentially fatal complication in orthopedic trauma patients, particularly following lower limb and hip-related fractures. While pharmacological prophylaxis is the cornerstone of prevention for patients at moderate to high risk, its use is a balance between efficacy and bleeding risk. Clinical pharmacists play [...]
CONCLUSIONS: A pharmacist-led PST intervention with ongoing education and counselling led to improved TTR and clinical outcomes in patients with MHV in China. [...]
CONCLUSIONS: The intervention was associated with a substantial increase in overall IVOS among eligible patients, supporting its effectiveness in promoting timely de-escalation from intravenous therapy. Clinical pharmacist-led initiatives optimize appropriate switching and antimicrobial utilization in stewardship. [...]
CONCLUSIONS: In the ATDOM program, patients with polypharmacy and DRPs associated with various factors are quite prevalent. These patients could be prioritized for pharmacist-led clinical medication review within multidisciplinary teams. An ongoing clinical trial will assess the effectiveness of medication review in reducing polypharmacy and DRPs. [...]
CONCLUSION: This scoping review highlighted emerging but heterogeneous use of CGM metrics in CGM-integrated pharmacists' services in diabetes care. While reported outcomes were consistently positive, most studies focused on clinical parameters, particularly A1C. Future research should place greater emphasis on evaluating humanistic and economic outcomes of CGM on pharmacist-involved diabetes [...]
CONCLUSIONS: PADL delivered by non-allergy nurses in the outpatient setting is safe and effective at removing low-risk penicillin allergy records. [...]
CONCLUSION: The factors identified in this study can be used to develop potential strategic plans to improve existing PMAC services and extend their implementation across the country. Future research should aim to quantify the effectiveness of PMAC services on patients' clinical/non-clinical outcomes. Positive findings could provide further evidence of the [...]
Piperacillin/tazobactam (PIPC/TAZ) and vancomycin (VCM) are frequently used in combination (PTV) to manage severe healthcare-associated infections, but are also associated with an increased risk of acute kidney injury (AKI). In 2019, Ogaki Municipal Hospital implemented pharmacist-led interventions aimed at reducing PTV use and mitigating AKI. This study evaluated the impact [...]
CONCLUSIONS: The ASPIRE intervention significantly improved medication appropriateness in patients admitted to an acute geriatric ward without reducing overall medication burden, resulting in a shift from inappropriate to appropriate polypharmacy. [...]
CONCLUSION: Preparing pharmacists for prescribing roles in the Netherlands requires integrating several new or expanded competencies into pharmacy education. Regardless of the prescribing model to be introduced, assuming responsibility for prescribing decisions and outcomes appears essential. [...]
CONCLUSION: Integrating The DBI Calculator© into pharmacist-led medication reviews supported deprescribing efforts and was effective at reducing the DBI score in older hospital inpatients. Further research is required to explore widespread implementation and sustainability. [...]
CONCLUSION: Pharmacists' activities, the extent of collaboration and outcomes of collaborative care varied. This information may help to support the implementation of new COPD-focused services. Further rigorously designed research is needed to explore the effect of collaborative community pharmacist-physician care in COPD management. [...]
CONCLUSION: Pharmacist-led MTM plays a crucial role in optimizing cancer pain management by reducing DRPs, improving adherence, minimizing adverse drug reactions, and enhancing patient satisfaction. It is an essential component of comprehensive, individualized care that ultimately improves the clinical outcomes and quality of life of patients with cancer. [...]
Prescription opioid risk mitigation is paramount to patient and community safety. Postoperative pain management prescriptions can lead to excess opioids in the home with many patients being unaware of proper disposal. The purpose of this initiative was to evaluate pharmacist impact on opioid safety outcomes in perioperative surgical pain management [...]
CONCLUSION: The KTA framework was a useful tool for implementing the pharmacist-led post-discharge medication review clinic, adapting and monitoring processes and improving knowledge of key stakeholders. Identified barriers and facilitators are relevant to implementing future clinic models. [...]
CONCLUSIONS: In this high-risk, remote setting, this pharmacist-supported, culturally adapted HF day-hospital model was associated with major reductions in HF rehospitalisations and strong implementation of contemporary therapy, supporting integrated, context-sensitive organisational models to improve HF care quality and equity. [...]
CONCLUSIONS: In this outpatient pain and palliative-care population, benzodiazepine-related dependence phenomena were common: 59.7% of patients met the criteria for dependence based on the pharmacist-led EMR review. The involvement of the pharmacist was essential, as this systematic evaluation would have been difficult to perform within routine medical consultations. The pharmacist's [...]
No abstract [...]
The management of hyperphosphatemia is of critical significance given its high prevalence among hemodialysis (HD) patients and its strong association with worse outcomes. Clinical pharmacists can play a crucial role in medication management, but there is a critical shortage. Currently, there is rarely study evaluating how pharmacists in different roles [...]
CONCLUSION: Pharmacist-led counseling significantly enhances understanding of antiarrhythmic therapy in supraventricular arrhythmia, supporting its integration into outpatient care in resource-limited settings. [...]
CONCLUSION: Patients and clinicians were generally supportive of potential pharmacist prescribing in the hemodialysis unit, contingent on several considerations for implementation. Interviews with additional stakeholders in other dialysis care settings could further inform strategies for broader adoption. [...]
CONCLUSIONS: In the ICU setting, PIs play a vital role in improving patient outcomes; however, standardization of evaluation methods is essential to ensure consistency, reduce subjectivity, and enhance the overall impact of such interventions. [...]
CONCLUSIONS: Although previous literature has shown that pharmacists improve quality-of-care measures in the ED, the findings of the current study suggest that ED pharmacists' services could be optimized further by targeting activities that reduce LOS and return visits. The study emphasizes the need for high-quality research on ED pharmacist practice [...]
Optimising medication adherence is essential for effective heart failure (HF) management, yet nonadherence remains common, particularly among hospitalised and advanced-stage patients. This study evaluated the internal consistency reliability and score association of the Medication Adherence Report Scales, MARS-5 and MARS-10, self-report questionnaires in clinical pharmacist-led adherence assessments in hospitalised HF [...]
CONCLUSIONS: Pharmacy-led services improved clinical outcomes, however there was lack of studies showing the economic and humanistic outcomes of these services. The need for standardized protocols and further research to establish their broader impacts should be considered. The findings support the continued integration and expansion of pharmacist roles in emergency [...]
No abstract [...]
BACKGROUND: Appropriate deprescribing of psychotropic, sedative, and anticholinergic potentially inappropriate medication (PSA-PIM) in older adults with polypharmacy can reduce the risk of adverse drug reactions, but is inconsistently implemented in primary care. The PARTNER intervention was designed to address challenges in PSA-PIM deprescribing at both provider and patient levels. [...]
CONCLUSION: Pharmacist-led deprescribing reduces inappropriate medication use in targeted settings, while pooled effects on total medication count and hard clinical outcomes remain uncertain. Variability in study designs and outcomes underscores the need for larger, thoroughly designed trials with standardized protocols, longer follow-up, and comprehensive evaluations of clinical, economic, and patient-reported [...]
Continuous glucose monitoring (CGM) has transformed diabetes care by enabling real-time tracking of glucose levels, improving glycemic control, reducing hypoglycemia, and enhancing quality of life. Despite their clinical benefits, CGM adoption remains inequitable, with underserved populations facing barriers such as low digital and health literacy, financial hardship, limited provider engagement, [...]
Prehabilitation has emerged as a proactive, multimodal strategy in perioperative care, aiming to enhance functional capacity and resilience before surgery through medical optimization, exercise, nutrition, and psychological support. Despite their multidisciplinary nature, pharmacists are underutilized in this evolving field. Pharmacists are uniquely positioned to advance prehabilitation by applying Medication Therapy [...]
CONCLUSION: Machine learning-guided pharmacist interventions improved TB treatment outcomes and reduced costs. Future multicenter studies should validate subtype-specific benefits. [...]
Background: Piperacillin-Tazobactam (PTZ) is often used to treat community-acquired intra-abdominal infections (CA-IAIs) despite common causative pathogens being susceptible to more narrow-spectrum agents. However, susceptibility to PTZ among these predominant pathogens has been declining. Antibiotic de-escalation to non-antipseudomonal beta-lactams whenever possible is an important strategy to prevent the development of resistance [...]
Despite their expanding patient-facing roles and increased involvement in mental health services, pharmacists' interactions with clients remain largely medicines-focused. This limitation is compounded by a reported lack of pharmacists' confidence and inadequate training in both mental health conditions and communication skills. The interrelated concepts of person-centredness, therapeutic alliance, and empathy [...]
Background: Asymptomatic bacteriuria (ASB) is frequently overtreated in emergency departments (EDs), contributing to antimicrobial resistance without improving clinical outcomes. The rapid pace of clinical decision-making and high patient turnover in the ED further predispose clinicians to unnecessary antibiotic prescribing. Methods: A quasi-experimental study was conducted in the ED of a [...]
Background: Antimicrobial resistance (AMR) is accelerating globally, driven by widespread inappropriate antibiotic use and diagnostic uncertainty in primary care. Pharmcist-led point-of-care testing (POCTs) has emerged as a promising model to optimize antibiotic prescribing, improve triage, and strengthen antimicrobial stewardship (AMS). Methods: This scoping review synthesizes current evidence, regulatory models, and [...]
CONCLUSION: Clinical pharmacist-led interventions significantly enhance medication adherence and quality of life and may reduce relapse risk among patients with BD-I. However, given the limited number of studies and small pooled sample sizes, the overall evidence remains preliminary, and the findings should be interpreted cautiously rather than as definitive conclusions. [...]
CONCLUSIONS: Educational podcasts can improve medical students' attitude towards physician-pharmacist collaboration, particularly when introduced early in the curriculum. Podcasts offer a flexible and scalable format to enhance role understanding and promote interprofessional awareness among students. [...]
Fujihara H, Kishimoto M, Kose E, Shinonaga H, Tanaka E, Nakamichi M, Mizokami F. The impact of pharmacist intervention on FIM gain in patients with musculoskeletal disorders in Kaifukuki rehabilitation wards. Jpn J Compr Rehabil Sci 2025; 16: 53-59. [...]
CONCLUSIONS: These pilot results suggest that a pharmacist-led SDOH program may be effective in addressing patient barriers, demonstrated by high acceptance rate and perceived benefit of interventions and improved clinical outcomes. [...]
CONCLUSION: ASP led by a pharmacist belonging to an AST in the open ICU contributed to long-term appropriate antimicrobial use of carbapenems and anti-pseudomonal β-lactams, and DOT for non-pseudomonal β-lactams. [...]
Type 2 diabetes mellitus (T2D) affects over 460 million people worldwide and profoundly diminishes their quality of life. Its onset is driven by obesity, sedentary behavior, and genetic predisposition, leading to insulin resistance, progressive beta-cell dysfunction, and complications such as cardiovascular disease and nonalcoholic fatty liver disease (NAFLD). Effective management [...]
CONCLUSION: The implementation of standardized MTMs by pharmacists within the medical consortium effectively extended pharmaceutical care to the home setting. This intervention improved pain relief, enhanced medication adherence, and reduced anxiety among cancer pain patients; these findings support the potential for broader clinical application of this pharmacist-led model within integrated [...]
CONCLUSIONS: Prescribers and clinical pharmacists both responded similarly and consistently to correct inappropriate DOAC prescriptions in response to EHR asynchronous notifications. While pharmacists did not outperform prescribers overall, they demonstrated more nuanced application of medication prescribing guidelines in complex cases. Engaging clinical pharmacists directly may be an efficient implementation strategy [...]
Social isolation and Loneliness (SIL) represent a critical public health issue as they are strongly associated with adverse physical, mental and emotional health and wellbeing outcomes. Community pharmacies are accessible and frequently accessed healthcare locations and are potentially valuable settings for interventions designed to support patients experiencing SIL. However, a [...]
INTRODUCTION: Hereditary diffuse leukoencephalopathy with spheroids (HDLS), caused by CSF1R mutations, is a rare autosomal dominant leukodystrophy characterized by rapid neurological decline. Hematopoietic stem cell transplantation (HSCT) is a promising treatment, but the risk of post-transplant complications such as invasive fungal disease (IFD) remains underexplored. Microglial dysfunction in CSF1R-related disorder [...]
CONCLUSIONS: The implementation of a structured algorithm for penicillin allergy reassessment in emergency settings is both effective and safe. Its application facilitates antibiotic optimization, improves patient safety, and reduces broad-spectrum antibiotic use. This study highlights the role of hospital pharmacists in drug allergy management and antimicrobial stewardship. [...]
CONCLUSIONS: Capturing impact of pharmacist prescribing requires assessment of outcomes across multiple dimensions. [...]
Introduction: Type 1 diabetes mellitus (T1DM) is a condition requiring lifelong insulin therapy and specialized care. Access to endocrinologists remains limited, leaving many primary care providers (PCPs) to manage insulin therapies and diabetes technologies. Pharmacists have demonstrated effectiveness in type 2 diabetes management, yet their role in T1DM within primary [...]
Long-acting injectable (LAI) antipsychotic formulations can improve outcomes related to poor adherence in psychiatric patients. However, LAIs are known to be high-risk medications that are prone to medication errors, especially during transitions of care. This is often due to incomplete or incorrect medication reconciliation, inadequate documentation, or lapses in communication. [...]
INTRODUCTION: Considering the expected decrease in psychiatrists due to retirements and fewer individuals entering the field, it is important to examine the pharmacist's role in improving mental health outcomes. This study evaluated pharmacist treatment of depression in a behavioral health-integrated virtual (BHIV) clinic where patients were generally followed twice monthly [...]
CONCLUSIONS: Community pharmacists have the potential to provide expanded professional services and practise to their full scope to enhance healthcare accessibility and patient outcomes. Multilevel approaches that address logistic, collaborative, systematic, and financial challenges are needed. Future research should focus on large-scale evaluations and long-term impacts to build a stronger [...]
CONCLUSION: In suboptimally managed type 2 diabetes, augmentation of a standard diabetes management protocol with rtCGMs was associated with significantly greater HbA1c reduction. [...]
CONCLUSIONS: The pharmacist-led service significantly improved glycaemic control, LDL cholesterol, and self-care behaviour. These findings highlight pharmacists' potential to enhance diabetes management and support public health efforts. [...]
Theranostics-a rapidly advancing field that integrates diagnostic imaging with targeted radiotherapy-holds great promise for revolutionizing cancer care. As this paradigm expands, a major challenge to its success lies in building and sustaining a skilled workforce, particularly in radiopharmaceutical development and delivery. A critical yet underrecognized member of this workforce is [...]
CONCLUSION: The EAHOP model can supplement existing models of pharmacy intervention in residential care by providing organised multidisciplinary collaboration between the General Practitioner, nursing, pharmacist and allied health disciplines. [...]
CONCLUSION: This systematic review provides evidence that pharmacist prescribing has a positive effect on therapeutic outcomes, and that pharmacist prescribing is comparable or better than medical prescribing in secondary care. [...]
CONCLUSION: This is the first qualitative study examining a pharmacist prescribing pilot outside Anglo-Saxon countries based on experiences from a real national pilot. Findings indicate positive experiences among stakeholders and support for implementation of pharmacist prescriber in Slovenia, with implications for broader applicability. [...]
CONCLUSION: The positive impact of pharmacist interventions on this patient cohort is evident despite the variability across settings and intervention designs, reflecting the adaptability of pharmacist services. Results also suggest the need for standardized models of care and consistent outcome reporting. [...]
CONCLUSIONS: Pharmacist-managed care for hypertension is an economical and effective strategy in China. These findings support policies that promote the integration of pharmaceutical care into chronic disease management and healthcare payment systems. [...]
CONCLUSION: There was a clear increase in pharmacist prescribing for eligible drugs in the eligible population post-policy implementation. Pharmacists in Ontario appear to be prescribing within policy limits for uncomplicated UTIs and LD prophylaxis. [...]
CONCLUSION: The New Mexico P5 Summit underscored the potential of APPh to mitigate primary care shortages and improve healthcare quality, access, and equity. The collaborative strategies and workgroup initiatives developed provide a framework for legislative, workforce, and payment reforms that leverage pharmacists' expertise. Ongoing stakeholder engagement will be essential to [...]
CONCLUSION: Pharmacist-prescribed UPA can enhance access to EC. Education, reimbursement, and support barriers must be addressed, in addition to legislation expansion, to enhance implementation. [...]
CONCLUSION: Pharmacist-led collaborative care for opioid dependence is feasible and acceptable and can provide an at least equivalent standard of care to usual care. Further research is required to establish how collaborative care can maximise prescriber capacity at scale. [...]
Although short-term benefits of clinical pharmacist involvement-such as improved medication adherence and risk-factor control-have been reported in cardiovascular patients, evidence on its impact on long-term outcomes remains limited and inconsistent. We retrospectively reviewed 100 in-patients with cardiovascular diseases treated at our center from January 2019 to December 2021 and followed [...]
CONCLUSION: In nine out of twelve studies, interventions led by pharmacists were found to be effective in improving medication adherence in patients with multimorbidity. Effective interventions showed significant improvement in medication adherence in the intervention group compared with the usual care group. These interventions included counselling sessions, medication management, and [...]
CONCLUSION: This study develops an innovative pharmaceutical service model for drug-susceptible TB patients. The model achieves higher plasma concentrations of INH and RFP, improves treatment efficacy, and reduces the incidence of neutropenia. These findings highlight the clinical significance and potential application value of this model in optimizing TB management. [...]
CONCLUSION AND RELEVANCE: The pharmacists-led iron deficiency transitions of care service can improve attainment of follow-up labs and provision of IV iron maintenance doses during care transitions from inpatient to outpatient settings. [...]
Pharmacist & Outcomes – Open Acess (Free PDF)
CONCLUSIONS: These findings suggest that the physician-pharmacist collaborative model could improve the long-term quality and efficiency of T2D management and reduce medical costs in underresourced areas globally. Patients with T2D, especially those with central obesity or high cardiovascular risk, may benefit more from collaborative clinics. [...]
CONCLUSIONS: This underpowered study found no evidence of pain differences between ABI-MTM and SMC, tentatively suggesting possible alcohol-opioid co-use improvements associated with the intervention without worsening pain. [...]
CONCLUSIONS: This evaluation furthers what is understood regarding barriers to implementing care bundles within rural healthcare contexts. Our findings suggested that clinicians in rural settings felt constrained in their ability to take on new tasks and expand their practice models due to staffing shortages and heavy workload demands. Some clinicians [...]
CONCLUSIONS: This study identified priority outcomes for evaluating the impact of pharmacist prescribing and their measurability, encompassing clinical, safety, economic, and patient perspectives. [...]
CONCLUSION: Spanish-speaking patients exposed to clinical pharmacist care observed significant improvements in glycemic control and timely preventative care screening. [...]
Despite the broad coverage offered by Taiwan's National Health Insurance system, attention-deficit/hyperactivity disorder (ADHD) care continues to face a critical "leaky pipeline" problem. There is a clear gap between diagnostic prevalence and long-term treatment retention. This perspective article applies the SPIDER (Sample, Phenomenon of Interest, Design, Evaluation, Research type) framework [...]
CONCLUSIONS: This pilot study underscores the critical role of pharmacist-led education for patients with primary open-angle glaucoma in improving treatment outcomes, particularly in achieving IOP targets and therby reducing the risk of vision loss. Future research involving larger cohorts and longer follow-up is necessary to further validate these findings. [...]
CONCLUSIONS: The brief pharmacist-led intervention was effective in improving attitudes toward medication and behavioral adherence among patients receiving antipsychotic treatment in our study group. These findings underscore the importance of active pharmacist engagement for supporting medication adherence. [...]
CONCLUSIONS AND RELEVANCE: This cluster randomized trial found that a centralized consultant pharmacist model was feasible, integrated well into primary care workflows, and resulted in high practitioner acceptance of recommendations; however, it did not significantly reduce opioid or benzodiazepine prescribing or falls within 1 year. These results suggest that more [...]
CONCLUSION: Pharmacist-led interventions in interprofessional primary care settings contributed to the appropriateness of pharmacotherapy and satisfaction of older adults under evaluation for or living with a NCD after a six-month follow-up. [...]
CONCLUSION: This evaluation demonstrated the impact of clinical pharmacists serving as prescribers in improving COPD management in rural settings. The sustainment factors identified can be utilized to inform the expansion of similar, team-based healthcare programs across rural settings. [...]
CONCLUSIONS AND RELEVANCE: This large-scale cohort study found that the use of an FPS was not associated with lower risk of death or hospitalization from any cause. However, the results generated a clinically important hypothesis that FPS use may be associated with slightly lower risk of death among older patients [...]
CONCLUSIONS: Our study demonstrates that comprehensive machine learning optimization can achieve strong predictive performance for identifying patients who would benefit from pharmacist intervention. The clinical prediction model, trained exclusively on clinical variables, provides a robust framework for personalized TB treatment resource allocation. Supportive transcriptomic analyses provide biological context but are [...]
CONCLUSIONS: Pharmacist-developed educational leaflets can support short-term knowledge acquisition and are perceived positively by women across age groups. These findings highlight the potential role of community pharmacies in delivering accessible written health education, while underscoring the need for future studies to assess long-term knowledge retention, behavioral outcomes, and topic-specific, targeted [...]
CONCLUSIONS AND RELEVANCE: In this randomized clinical trial, adding proactive, protocol-driven clinical pharmacist outreach into collaborative team-based care improved medication optimization and patient outcomes. This approach provides an evidence-based strategy for reducing the risk of developing severe hypoglycemia in individuals with T2D at high risk, enhancing patient safety, and potentially [...]
Background/Objectives: Older adults with chronic kidney disease (CKD) are particularly vulnerable to polypharmacy-related adverse outcomes due to altered pharmacokinetics, multimorbidity, and increased susceptibility to medication-related harm. Polypharmacy in CKD is associated with falls, hospitalizations, and functional decline. Clinical pharmacist-led medication reviews may mitigate these risks; however, access barriers limit their [...]
CONCLUSIONS: The clinical pharmacist-led MDT model enhances carbapenem-prescribing appropriateness and fosters interprofessional collaboration. Its implementation was associated with shorter hospital stays and improvements in key clinical indicators, including reduced ICU admission and mortality. However, the observed shifts in resistant pathogen epidemiology underscore that antimicrobial stewardship strategies must be integrated with [...]
Antimicrobial resistance (AMR) undermines clinical care. Thus, ensuring appropriate antimicrobial therapy is crucial in global and national AMR countermeasures. This narrative review aimed to summarize pharmacist-led antimicrobial stewardship interventions in Japan and discuss their practical and clinical significance across inpatient, outpatient, and community settings. In inpatient care, antimicrobial stewardship programs [...]
BACKGROUND: Venous thromboembolism (VTE) is a common and potentially fatal complication in orthopedic trauma patients, particularly following lower limb and hip-related fractures. While pharmacological prophylaxis is the cornerstone of prevention for patients at moderate to high risk, its use is a balance between efficacy and bleeding risk. Clinical pharmacists play [...]
CONCLUSIONS: A pharmacist-led PST intervention with ongoing education and counselling led to improved TTR and clinical outcomes in patients with MHV in China. [...]
CONCLUSIONS: In the ATDOM program, patients with polypharmacy and DRPs associated with various factors are quite prevalent. These patients could be prioritized for pharmacist-led clinical medication review within multidisciplinary teams. An ongoing clinical trial will assess the effectiveness of medication review in reducing polypharmacy and DRPs. [...]
CONCLUSION: This scoping review highlighted emerging but heterogeneous use of CGM metrics in CGM-integrated pharmacists' services in diabetes care. While reported outcomes were consistently positive, most studies focused on clinical parameters, particularly A1C. Future research should place greater emphasis on evaluating humanistic and economic outcomes of CGM on pharmacist-involved diabetes [...]
CONCLUSIONS: PADL delivered by non-allergy nurses in the outpatient setting is safe and effective at removing low-risk penicillin allergy records. [...]
CONCLUSION: The factors identified in this study can be used to develop potential strategic plans to improve existing PMAC services and extend their implementation across the country. Future research should aim to quantify the effectiveness of PMAC services on patients' clinical/non-clinical outcomes. Positive findings could provide further evidence of the [...]
Piperacillin/tazobactam (PIPC/TAZ) and vancomycin (VCM) are frequently used in combination (PTV) to manage severe healthcare-associated infections, but are also associated with an increased risk of acute kidney injury (AKI). In 2019, Ogaki Municipal Hospital implemented pharmacist-led interventions aimed at reducing PTV use and mitigating AKI. This study evaluated the impact [...]
CONCLUSION: Preparing pharmacists for prescribing roles in the Netherlands requires integrating several new or expanded competencies into pharmacy education. Regardless of the prescribing model to be introduced, assuming responsibility for prescribing decisions and outcomes appears essential. [...]
CONCLUSION: Pharmacists' activities, the extent of collaboration and outcomes of collaborative care varied. This information may help to support the implementation of new COPD-focused services. Further rigorously designed research is needed to explore the effect of collaborative community pharmacist-physician care in COPD management. [...]
CONCLUSION: Pharmacist-led MTM plays a crucial role in optimizing cancer pain management by reducing DRPs, improving adherence, minimizing adverse drug reactions, and enhancing patient satisfaction. It is an essential component of comprehensive, individualized care that ultimately improves the clinical outcomes and quality of life of patients with cancer. [...]
CONCLUSION: The KTA framework was a useful tool for implementing the pharmacist-led post-discharge medication review clinic, adapting and monitoring processes and improving knowledge of key stakeholders. Identified barriers and facilitators are relevant to implementing future clinic models. [...]
CONCLUSIONS: In this outpatient pain and palliative-care population, benzodiazepine-related dependence phenomena were common: 59.7% of patients met the criteria for dependence based on the pharmacist-led EMR review. The involvement of the pharmacist was essential, as this systematic evaluation would have been difficult to perform within routine medical consultations. The pharmacist's [...]
The management of hyperphosphatemia is of critical significance given its high prevalence among hemodialysis (HD) patients and its strong association with worse outcomes. Clinical pharmacists can play a crucial role in medication management, but there is a critical shortage. Currently, there is rarely study evaluating how pharmacists in different roles [...]
Optimising medication adherence is essential for effective heart failure (HF) management, yet nonadherence remains common, particularly among hospitalised and advanced-stage patients. This study evaluated the internal consistency reliability and score association of the Medication Adherence Report Scales, MARS-5 and MARS-10, self-report questionnaires in clinical pharmacist-led adherence assessments in hospitalised HF [...]
No abstract [...]
BACKGROUND: Appropriate deprescribing of psychotropic, sedative, and anticholinergic potentially inappropriate medication (PSA-PIM) in older adults with polypharmacy can reduce the risk of adverse drug reactions, but is inconsistently implemented in primary care. The PARTNER intervention was designed to address challenges in PSA-PIM deprescribing at both provider and patient levels. [...]
CONCLUSION: Pharmacist-led deprescribing reduces inappropriate medication use in targeted settings, while pooled effects on total medication count and hard clinical outcomes remain uncertain. Variability in study designs and outcomes underscores the need for larger, thoroughly designed trials with standardized protocols, longer follow-up, and comprehensive evaluations of clinical, economic, and patient-reported [...]
Background: Piperacillin-Tazobactam (PTZ) is often used to treat community-acquired intra-abdominal infections (CA-IAIs) despite common causative pathogens being susceptible to more narrow-spectrum agents. However, susceptibility to PTZ among these predominant pathogens has been declining. Antibiotic de-escalation to non-antipseudomonal beta-lactams whenever possible is an important strategy to prevent the development of resistance [...]
CONCLUSION: Machine learning-guided pharmacist interventions improved TB treatment outcomes and reduced costs. Future multicenter studies should validate subtype-specific benefits. [...]
Despite their expanding patient-facing roles and increased involvement in mental health services, pharmacists' interactions with clients remain largely medicines-focused. This limitation is compounded by a reported lack of pharmacists' confidence and inadequate training in both mental health conditions and communication skills. The interrelated concepts of person-centredness, therapeutic alliance, and empathy [...]
Background: Asymptomatic bacteriuria (ASB) is frequently overtreated in emergency departments (EDs), contributing to antimicrobial resistance without improving clinical outcomes. The rapid pace of clinical decision-making and high patient turnover in the ED further predispose clinicians to unnecessary antibiotic prescribing. Methods: A quasi-experimental study was conducted in the ED of a [...]
Background: Antimicrobial resistance (AMR) is accelerating globally, driven by widespread inappropriate antibiotic use and diagnostic uncertainty in primary care. Pharmcist-led point-of-care testing (POCTs) has emerged as a promising model to optimize antibiotic prescribing, improve triage, and strengthen antimicrobial stewardship (AMS). Methods: This scoping review synthesizes current evidence, regulatory models, and [...]
CONCLUSION: Clinical pharmacist-led interventions significantly enhance medication adherence and quality of life and may reduce relapse risk among patients with BD-I. However, given the limited number of studies and small pooled sample sizes, the overall evidence remains preliminary, and the findings should be interpreted cautiously rather than as definitive conclusions. [...]
CONCLUSIONS: Educational podcasts can improve medical students' attitude towards physician-pharmacist collaboration, particularly when introduced early in the curriculum. Podcasts offer a flexible and scalable format to enhance role understanding and promote interprofessional awareness among students. [...]
Fujihara H, Kishimoto M, Kose E, Shinonaga H, Tanaka E, Nakamichi M, Mizokami F. The impact of pharmacist intervention on FIM gain in patients with musculoskeletal disorders in Kaifukuki rehabilitation wards. Jpn J Compr Rehabil Sci 2025; 16: 53-59. [...]
Type 2 diabetes mellitus (T2D) affects over 460 million people worldwide and profoundly diminishes their quality of life. Its onset is driven by obesity, sedentary behavior, and genetic predisposition, leading to insulin resistance, progressive beta-cell dysfunction, and complications such as cardiovascular disease and nonalcoholic fatty liver disease (NAFLD). Effective management [...]
CONCLUSIONS: Prescribers and clinical pharmacists both responded similarly and consistently to correct inappropriate DOAC prescriptions in response to EHR asynchronous notifications. While pharmacists did not outperform prescribers overall, they demonstrated more nuanced application of medication prescribing guidelines in complex cases. Engaging clinical pharmacists directly may be an efficient implementation strategy [...]
Social isolation and Loneliness (SIL) represent a critical public health issue as they are strongly associated with adverse physical, mental and emotional health and wellbeing outcomes. Community pharmacies are accessible and frequently accessed healthcare locations and are potentially valuable settings for interventions designed to support patients experiencing SIL. However, a [...]
INTRODUCTION: Hereditary diffuse leukoencephalopathy with spheroids (HDLS), caused by CSF1R mutations, is a rare autosomal dominant leukodystrophy characterized by rapid neurological decline. Hematopoietic stem cell transplantation (HSCT) is a promising treatment, but the risk of post-transplant complications such as invasive fungal disease (IFD) remains underexplored. Microglial dysfunction in CSF1R-related disorder [...]
CONCLUSIONS: The implementation of a structured algorithm for penicillin allergy reassessment in emergency settings is both effective and safe. Its application facilitates antibiotic optimization, improves patient safety, and reduces broad-spectrum antibiotic use. This study highlights the role of hospital pharmacists in drug allergy management and antimicrobial stewardship. [...]
Long-acting injectable (LAI) antipsychotic formulations can improve outcomes related to poor adherence in psychiatric patients. However, LAIs are known to be high-risk medications that are prone to medication errors, especially during transitions of care. This is often due to incomplete or incorrect medication reconciliation, inadequate documentation, or lapses in communication. [...]
INTRODUCTION: Considering the expected decrease in psychiatrists due to retirements and fewer individuals entering the field, it is important to examine the pharmacist's role in improving mental health outcomes. This study evaluated pharmacist treatment of depression in a behavioral health-integrated virtual (BHIV) clinic where patients were generally followed twice monthly [...]
CONCLUSIONS: The pharmacist-led service significantly improved glycaemic control, LDL cholesterol, and self-care behaviour. These findings highlight pharmacists' potential to enhance diabetes management and support public health efforts. [...]
CONCLUSION: The EAHOP model can supplement existing models of pharmacy intervention in residential care by providing organised multidisciplinary collaboration between the General Practitioner, nursing, pharmacist and allied health disciplines. [...]
CONCLUSION: This systematic review provides evidence that pharmacist prescribing has a positive effect on therapeutic outcomes, and that pharmacist prescribing is comparable or better than medical prescribing in secondary care. [...]
CONCLUSION: This is the first qualitative study examining a pharmacist prescribing pilot outside Anglo-Saxon countries based on experiences from a real national pilot. Findings indicate positive experiences among stakeholders and support for implementation of pharmacist prescriber in Slovenia, with implications for broader applicability. [...]
CONCLUSIONS: Pharmacist-managed care for hypertension is an economical and effective strategy in China. These findings support policies that promote the integration of pharmaceutical care into chronic disease management and healthcare payment systems. [...]
CONCLUSION: There was a clear increase in pharmacist prescribing for eligible drugs in the eligible population post-policy implementation. Pharmacists in Ontario appear to be prescribing within policy limits for uncomplicated UTIs and LD prophylaxis. [...]
CONCLUSION: Pharmacist-led collaborative care for opioid dependence is feasible and acceptable and can provide an at least equivalent standard of care to usual care. Further research is required to establish how collaborative care can maximise prescriber capacity at scale. [...]
Although short-term benefits of clinical pharmacist involvement-such as improved medication adherence and risk-factor control-have been reported in cardiovascular patients, evidence on its impact on long-term outcomes remains limited and inconsistent. We retrospectively reviewed 100 in-patients with cardiovascular diseases treated at our center from January 2019 to December 2021 and followed [...]
CONCLUSION: In nine out of twelve studies, interventions led by pharmacists were found to be effective in improving medication adherence in patients with multimorbidity. Effective interventions showed significant improvement in medication adherence in the intervention group compared with the usual care group. These interventions included counselling sessions, medication management, and [...]
CONCLUSION: This study develops an innovative pharmaceutical service model for drug-susceptible TB patients. The model achieves higher plasma concentrations of INH and RFP, improves treatment efficacy, and reduces the incidence of neutropenia. These findings highlight the clinical significance and potential application value of this model in optimizing TB management. [...]
CONCLUSION: Broad EMP prescriptive authority through CPAs enables independent resolution of postdischarge prescription issues, improving care continuity, potentially reducing ED revisits, and sparing provider time to optimally take care of patients. This model can serve as a framework for other institutions aiming to optimize pharmacist-driven transitions of care. [...]
INTRODUCTION: Transitions of care (TOC) between hospital, ambulatory and home settings for high-risk adults with chronic diseases are complex, costly and often result in poor health outcomes. Suboptimal care transitions lead to medication errors, non-adherence, decreased self-management skills and inadequate follow-up, all of which contribute to readmissions or emergency department [...]
CONCLUSION: Multilevel alignment and continuous adaptation efforts contributed to successful implementation of a pharmacist-led RPM intervention for hypertension with improvement in reach over time. We share our insights as a resource for primary care practitioners, organizations, and policy makers seeking to implement RPM for hypertension. [...]
CONCLUSIONS: Pharmacist management yielded more consistent quality of care and similar timeliness and parent ratings as pediatrician management of electronic ADHD medication refill requests.Study registration number: ClinicalTrials.gov NCT06388694. [...]
CONCLUSIONS: This study demonstrates the value of integrating pharmacists into HCV treatment teams to meet public health needs. [...]
CONCLUSION: Pharmacist-led education significantly improved insulin injection techniques. Integrating pharmacists into routine diabetes care and reinforcing education is essential to sustain these improvements. These findings underscore that clinical pharmacy interventions make a tangible difference in improving healthcare outcomes. [...]
CONCLUSION: While current pharmacist MTM payment modalities do not entirely compensate for pharmacist costs, pharmacists are successfully obtaining payment for their services. Future advocacy efforts need to focus on establishing consistent billing requirements and increasing payment for service sustainability, as well as educating pharmacists and billing professionals on billing opportunities. [...]
(1) Background: Pharmacist interventions are key to optimizing medication therapy and improving patient outcomes. The CLEO multidimensional tool assesses the clinical, economic, and organizational impact of these interventions, though its use in Portuguese hospital settings is limited. This study explored the predicted impact of pharmacist interventions in the Oncology Department [...]
Home blood pressure (BP) monitoring (HBPM) is fundamental to effective hypertension management. Incorporating community pharmacists into care delivery, especially via hybrid case management methods utilizing digital telemonitoring, presents a promising strategy for enhancing BP control and patient self-management. Nonetheless, the efficacy of these interventions at a national level remains inadequately [...]
BACKGROUND: Polypharmacy is a major and growing challenge for patient safety and health outcomes, and associated with inefficient use of resources. Management requires balancing therapeutic benefits and risks, aligned with clinical and patient priorities. High-quality evidence supporting current guidance for the management of polypharmacy is scarce. The aim of the [...]
Background: Clinical pharmacy services (CPSs) play a key role in ensuring medication safety, optimizing pharmacotherapy, and improving patient outcomes. While their benefits are well-documented globally, their specific impact within the Saudi healthcare system remains underexplored. Objective: This study aimed to evaluate the impact of pharmacist-led interventions in a tertiary medical [...]
CONCLUSIONS: Pharmacist involvement in CKD screening improves public understanding of CKD risk factors, facilitates earlier initiation of treatment, and contributes to better long‑term patient outcomes. [...]
CONCLUSION: Pharmacists contribute to the effectiveness of health-focused NGOs through diverse responsibilities and adaptable roles that extend beyond medication management. This study provides a foundational description of how pharmacists working in multinational NGOs perceive their roles, contributions, and professional experiences. Findings highlight key responsibilities, attributes needed for success, and challenges [...]
CONCLUSION: Pharmacist-led medication reconciliation, focusing on the best possible medication history collection and direct contact with physicians, significantly increased the identification and resolution of discrepancies, underlining its role in enhancing patient safety. [...]
The recurrence rate of stroke, particularly ischaemic stroke, is considered high, which highlights the importance of secondary stroke prevention. Pharmacists are becoming increasingly involved in poststroke care. Ease of public access to community pharmacists provides opportunities for pharmacists to educate patients about the significance of secondary stroke prevention. The literature [...]
BACKGROUND: The scope of practice for community pharmacists is evolving globally. Policy drivers are to increase access to primary care, due to the lack of accessibility to general medical practitioners or inappropriate demand on emergency departments. Most implementation studies in this space have reported on determinants for pharmacist prescribing services. [...]
CONCLUSIONS: Pharmacist-led hypertension management under a CPA significantly improves BP control, time to goal, medication adherence, and reduces hospitalizations compared to physician-only care in a rural, underserved FQHC setting. [...]
CONCLUSION: Pharmacist interventions improve BP control in patients with diabetes and hypertension. [...]
CONCLUSION: This study demonstrates that prescriptions made by clinical pharmacists in collaboration with GPs, as specified in the CPA, improved PROs and clinical outcomes for predefined conditions. [...]
Improving adherence enhances therapeutic outcomes in hemodialysis patients; several approaches, including behavioral interventions, were utilized to improve adherence. Examine the effect of a pharmacist-led behavioral change technique (PL-BCT) intervention on hemodialysis patients' adherence to their complex therapeutic regimen and physical indices. Parallel-group, cluster-randomized, controlled trial, in which the patients were [...]
CONCLUSION: Several factors were identified that influenced successful implementation and delivery of pharmacist prescribing services for patients with mental illness in community care. Improved education and training in mental health along with a clearer definition of the pharmacist prescribing role may support optimal service delivery. Future work evaluating pharmacist prescribing [...]
CONCLUSION: Pharmacist-interpreted pt-qPCR significantly improves pathogen detection and optimizes antimicrobial therapy in LRTI patients. Its clinical use may enhance antibiotic stewardship, reduce ICU burden, and support precision medicine in respiratory infections. [...]
CONCLUSION: Remote pharmaceutical services delivered via a follow-up app effectively reduce the incidence of severe adverse drug reactions and improve medication knowledge, adherence, and quality of life in non-metastatic breast cancer patients. This model provides a viable new approach for out-of-hospital management and highlights the value of pharmacists in the [...]
CONCLUSION: Pharmacist-led chemotherapy counseling significantly improved psychological well-being and HRQoL among oncology patients, highlighting the valuable role of pharmacists in comprehensive cancer care, especially in low-resource settings. [...]
In this multicenter, nonrandomised comparative study, we evaluated the potential effectiveness of a program to promote the safe use of dipeptidyl peptidase-4 (DPP-4) inhibitors led by community pharmacists. The program facilitated early detection of gastrointestinal adverse events (GIAEs) in patients newly prescribed DPP-4 inhibitors and facilitated timely communication with physicians. [...]
Polypharmacy is prevalent in older people residing in care homes. Deprescribing, reducing or stopping harmful or unnecessary medicines, leads to improvements in patient- and health-system-orientated outcomes. This study identified the barriers and enablers to pharmacists proactively deprescribing in United Kingdon care homes. It draws on methods from behavioural science. Twenty-nine [...]
Chronic obstructive pulmonary disease (COPD), predicted to become the third leading cause of death by 2030 with 3 million annual fatalities, imposes significant health and economic burdens due to its diverse respiratory conditions. Effective management strategies include symptom relief, disease progression control, and exacerbation prevention through interventions like smoking cessation, [...]
CONCLUSION: This study demonstrates that interventions by clinical pharmacists during the medication review process effectively reduced the number of medications, PIMs, and DDIs while significantly improving adherence to treatment guidelines. [...]
INTRODUCTION: Many psychotropic drugs potentially prolong the QTc interval. The aim of this study was to investigate the feasibility of the pharmacist-supported implementation of a new local guideline for QTc monitoring at a psychiatric department and to gather preliminary data on the effectiveness of this intervention. [...]
CONCLUSIONS: This case study demonstrates that interventions by a clinical pharmacist prescriber during the medication review process resulted in improved clinical outcomes in the treatment of depression, as well as enhanced quality of life. It represents an important contribution to the development of pharmacist prescribing roles in depression management within [...]
A psychiatric pharmacist can play a critical role in addressing health disparities in black patients by managing both psychiatric and nonpsychiatric conditions. Black patients experience disparities in the treatment of both hypertension and mental health disorders, highlighting the need for innovative care models. This paper describes the integration of a [...]
CONCLUSION: Clinical pharmacist-driven AMSP can be effectively implemented irrespective of the cultural and geographical setting due to their ability to improve prescription practices. [...]
While deprescribing benzodiazepines and related drugs (BZRDs) is crucial for preventing prolonged use and their associated adverse effects, it presents challenges from a healthcare perspective, because of limited resources and time. Recently, a pharmacist-led deprescribing of BZRDs in the treatment of insomnia was introduced in Helsinki's primary care health centres. [...]
Medication reconciliation was adopted as a National Patient Safety Goal by the Joint Commission in 2005 and is now standard practice across care settings. More recently, the concept of medication optimization has gained attention, recognizing that safe medication use requires more than reconciliation alone. Home healthcare (HHC) is one setting [...]
No abstract [...]
With the advancement of digital technologies, pharmacist-led digital health interventions (DHI) have emerged as a promising strategy to improve hypertension management. This systematic review evaluated randomized controlled trials (RCTs) published from December 1996 to May 2024, identified via PubMed by incorporating key concepts including DHIs, pharmaceutical care, and hypertension. The [...]
CONCLUSIONS: This study demonstrated that the family pharmacist system improved TDDI prevention among underage individuals. However, its effectiveness was consistent regardless of the characteristics related to the utilization of the family pharmacist system, indicating that the trend of positively applying the system to those with these characteristics was not supported. [...]
Optimal guideline-directed medical therapy (GDMT) can reduce mortality, unplanned hospital admissions and improve quality of life for patients suffering from heart failure (HF). However, GDMT remains underused in primary care. Only a minority of patients on HF registers receive optimal GDMT in the UK. This suboptimal care is compounded by [...]